Is active surveillance an option for metachronous metastatic renal cell carcinoma?
作者信息
Ficarra Vincenzo, Mosca Alessandra, Rossanese Marta, Subba Enrica, Giannarini Gianluca
机构信息
Department of Human and Pediatric Pathology "Gaetano Barresi", Urologic Section, University of Messina, Messina, Italy.
Oncology Unit, Maggiore della Carità University Hospital, Novara, Italy.
出版信息
Ann Transl Med. 2019 Mar;7(5):84. doi: 10.21037/atm.2019.01.08.
Abstract
摘要
相似文献
1
Is active surveillance an option for metachronous metastatic renal cell carcinoma?主动监测是否适用于异时性转移性肾细胞癌？
Ann Transl Med. 2019 Mar;7(5):84. doi: 10.21037/atm.2019.01.08.
2
Risk factors for metachronous bilateral renal cell carcinoma: A surveillance, epidemiology, and end results analysis.同期双侧肾癌的风险因素：监测、流行病学和最终结果分析。
Cancer. 2019 Jan 15;125(2):232-238. doi: 10.1002/cncr.31689. Epub 2018 Dec 18.
3
Re: Brian I. Rini, Tanya B. Dorff, Paul Elson, et al. Active Surveillance in Metastatic Renal-cell Carcinoma: A Prospective, Phase 2 Trial. Lancet Oncol Lancet 2016;17:1317-24: Active Surveillance in Metastatic Renal Cell Carcinoma: Option or Exception?回复：布莱恩·I·里尼、坦尼娅·B·多尔夫、保罗·埃尔森等。转移性肾细胞癌的主动监测：一项前瞻性2期试验。《柳叶刀·肿瘤学》，《柳叶刀》2016年；17:1317 - 24：转移性肾细胞癌的主动监测：是一种选择还是例外？
Eur Urol. 2017 May;71(5):e139-e140. doi: 10.1016/j.eururo.2016.09.034. Epub 2016 Sep 29.
4
Metachronous bilateral renal cell carcinoma: risk assessment, prognosis and relevance of the primary-free interval.异时性双侧肾细胞癌：风险评估、预后及无原发瘤间期的相关性
J Urol. 2007 Jun;177(6):2081-6; discussion 2086-7. doi: 10.1016/j.juro.2007.01.122.
5
Metachronous pancreatic metastases from renal cell carcinoma: is there a place of Active-Surveillance before deferred deliberately Molecular Target Agent?肾细胞癌异时性胰腺转移：在有意推迟使用分子靶向药物之前，主动监测是否可行？
World J Surg Oncol. 2016 Aug 23;14(1):222. doi: 10.1186/s12957-016-0939-9.
6
Metachronous renal cell carcinoma with metastasis to the urinary bladder, and distant organs, 28 years after radical nephrectomy: a case report.根治性肾切除术后 28 年并发膀胱癌转移和远处器官转移的异时性肾细胞癌：病例报告。
BMC Urol. 2019 Dec 27;19(1):136. doi: 10.1186/s12894-019-0521-1.
7
Metachronous metastasis of renal cell carcinoma to the urinary bladder: a case report.肾细胞癌异时性转移至膀胱：一例报告
Ther Adv Urol. 2017 Nov 3;10(1):29-32. doi: 10.1177/1756287217738986. eCollection 2018 Jan.
8
Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.肿瘤大小不能预测小肾癌的转移风险或预后。
J Urol. 2008 May;179(5):1719-26. doi: 10.1016/j.juro.2008.01.018. Epub 2008 Mar 17.
9
Metachronous isolated locally advanced pancreatic metastasis from chromophobe renal cell carcinoma.来自肾嫌色细胞癌的异时性孤立性局部晚期胰腺转移
Int J Surg Case Rep. 2019;60:196-199. doi: 10.1016/j.ijscr.2019.05.046. Epub 2019 Jun 5.
10
Surgical resection of metastatic renal cell carcinoma: The University of Iowa experience.转移性肾细胞癌的手术切除：爱荷华大学的经验。
Urol Oncol. 1997 May-Jun;3(3):99-101. doi: 10.1016/s1078-1439(97)00062-8.
引用本文的文献
1
De Novo Renal Cell Carcinoma in Kidney Transplant Recipients: Incidence, Outcomes, and Therapeutic Challenges.肾移植受者中的新发肾细胞癌：发病率、结局及治疗挑战
Cancers (Basel). 2025 Jun 30;17(13):2200. doi: 10.3390/cancers17132200.
2
Comorbidity and frailty assessment in renal cell carcinoma patients.肾细胞癌患者的合并症和衰弱评估。
World J Urol. 2021 Aug;39(8):2831-2841. doi: 10.1007/s00345-021-03632-6. Epub 2021 Feb 22.
本文引用的文献
1
Predictive role of changes in the tumor burden and International Metastatic Renal Cell Carcinoma Database Consortium class during active surveillance for metastatic renal cell carcinoma.转移性肾细胞癌主动监测期间肿瘤负荷变化及国际转移性肾细胞癌数据库联盟分类的预测作用
Urol Oncol. 2018 Dec;36(12):526.e13-526.e18. doi: 10.1016/j.urolonc.2018.08.018. Epub 2018 Oct 6.
2
Incidence and Outcomes of Delayed Targeted Therapy After Cytoreductive Nephrectomy for Metastatic Renal-Cell Carcinoma: A Nationwide Cancer Registry Study.肾细胞癌转移患者细胞减瘤性肾切除术后靶向治疗延迟的发生率和结局：一项全国癌症登记研究。
Clin Genitourin Cancer. 2018 Dec;16(6):e1221-e1235. doi: 10.1016/j.clgc.2018.08.001. Epub 2018 Aug 25.
3
Prognostic Significance of Pancreatic Metastases from Renal Cell Carcinoma in Patients Treated with Tyrosine Kinase Inhibitors.酪氨酸激酶抑制剂治疗的肾细胞癌患者胰腺转移的预后意义
Anticancer Res. 2018 Jan;38(1):359-365. doi: 10.21873/anticanres.12230.
4
Renal cell carcinoma.肾细胞癌。
Nat Rev Dis Primers. 2017 Mar 9;3:17009. doi: 10.1038/nrdp.2017.9.
5
Re: Brian I. Rini, Tanya B. Dorff, Paul Elson, et al. Active Surveillance in Metastatic Renal-cell Carcinoma: A Prospective, Phase 2 Trial. Lancet Oncol Lancet 2016;17:1317-24: Active Surveillance in Metastatic Renal Cell Carcinoma: Option or Exception?回复：布莱恩·I·里尼、坦尼娅·B·多尔夫、保罗·埃尔森等。转移性肾细胞癌的主动监测：一项前瞻性2期试验。《柳叶刀·肿瘤学》，《柳叶刀》2016年；17:1317 - 24：转移性肾细胞癌的主动监测：是一种选择还是例外？
Eur Urol. 2017 May;71(5):e139-e140. doi: 10.1016/j.eururo.2016.09.034. Epub 2016 Sep 29.
6
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.肾细胞癌：ESMO 诊断、治疗及随访临床实践指南
Ann Oncol. 2016 Sep;27(suppl 5):v58-v68. doi: 10.1093/annonc/mdw328.
7
Active surveillance in metastatic renal-cell carcinoma: a prospective, phase 2 trial.转移性肾细胞癌的主动监测：一项前瞻性2期试验。
Lancet Oncol. 2016 Sep;17(9):1317-24. doi: 10.1016/S1470-2045(16)30196-6. Epub 2016 Aug 3.
8
Local treatments for metastases of renal cell carcinoma: a systematic review.局部治疗肾细胞癌转移：系统评价。
Lancet Oncol. 2014 Nov;15(12):e549-61. doi: 10.1016/S1470-2045(14)70235-9. Epub 2014 Oct 26.
9
Subcentimeter pulmonary nodules are not associated with disease progression in patients with renal cell carcinoma.亚厘米级肺结节与肾细胞癌患者的疾病进展无关。
J Urol. 2015 Mar;193(3):776-82. doi: 10.1016/j.juro.2014.09.020. Epub 2014 Sep 18.
10
Kidney cancer: Characterizing late recurrence of renal cell carcinoma.肾癌：肾细胞癌晚期复发的特征分析
Nat Rev Urol. 2013 Dec;10(12):687-9. doi: 10.1038/nrurol.2013.239. Epub 2013 Oct 29.
Zotero 插件